Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Federica Arnoldi"'
Autor:
Andrea Galbusera, Federica Arnoldi, Annalisa Perna, Jessica Caprioli, Silvia Orisio, Sara Bucchioni, Paola Bettinaglio, Marina Noris
Publikováno v:
Clinical Biochemistry. 35:363-368
Objectives: Conflicting results on the relationship between M235T polymorphism of angiotensinogen (AGT) gene and diabetic nephropathy are reported in the literature, probably due to the small number of subjects, to different inclusion criteria and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::458d1c4269b589bcf5edf52cec1c4558
https://doi.org/10.1016/s0009-9120(02)00308-9
https://doi.org/10.1016/s0009-9120(02)00308-9
Autor:
Giuseppe Remuzzi, Maria Lesti, Roberto Pisoni, Flavio Gaspari, Annalisa Perna, Ilaria Ciocca, Piero Ruggenenti, Lidia Mosconi, Federica Arnoldi
Publikováno v:
Kidney International. 58(5):2093-2101
Pretreatment blood pressure reliably predicts progression of chronic nephropathies. Background Random, nontimed blood pressure (BP) measurements in the outpatient clinic may fail to provide reliable information on actual daily BP control in renal pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23a68226ee4c32bf07739171d2c31208
Autor:
Anelja Parvanova Ilieva, Antonio Bossi, Piero Ruggenenti, Alessandro Roberto Dodesini, Anna Fassi, Roberto Trevisan, Flavio Gaspari, Ilian Iliev, Giulia Gherardi, Annalisa Perna, Nadia Rubis, Giuseppe Remuzzi, Varusca Brusegan, Bogdan Ene-Iordache, Federica Arnoldi, Simona Bruno, Maria Ganeva
Publikováno v:
The New England journal of medicine. 351(19)
BACKGROUND: The multicenter double-blind, randomized Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) was designed to assess whether angiotensin-converting-enzyme inhibitors and non-dihydropyridine calcium-channel blockers, alone or in com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28e52d5de967a9938affa3f9b82b4268
https://pubmed.ncbi.nlm.nih.gov/15981445
https://pubmed.ncbi.nlm.nih.gov/15981445
Autor:
Piero Ruggenenti, Borislav D. Dimitrov, Ilian Iliev, Federica Arnoldi, Jelka Zaletel, Giuseppe Remuzzi, Aneliya Parvanova
Publikováno v:
Diabetes Care. 25:2361-2361
Increased total plasma homocysteine (tHcy) level—secondary to excessive alcohol intake, cigarette smoking, or deficiency of methylene-tetrahydrofolate reductase—is one new identified risk factor for atherosclerotic cardiovascular diseases and for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da6c420247633d90b32a972277390070
https://doi.org/10.2337/diacare.25.12.2361
https://doi.org/10.2337/diacare.25.12.2361